Shore, Tsiporah B

Publications

Sort by

Co-Author Network

selected publications

Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. Transplantation and cellular therapy. 2023 Academic Article GET IT
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone marrow transplantation. 2023 Letter GET IT
Acute hemolytic anemia after hematopoietic stem cell transplantation: An unusual invader. 2023 GET IT
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023 Academic Article GET IT
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 2
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 4
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone marrow transplantation. 2022 Letter GET IT
Times cited: 3
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes. Leukemia & lymphoma. 2021 Academic Article GET IT
Times cited: 1
Colonization with Gastrointestinal Pathogens Prior to Hematopoietic Cell Transplantation and Associated Clinical Implications. Transplantation and cellular therapy. 2021 Academic Article GET IT
Times cited: 2
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma. Leukemia & lymphoma. 2021 Academic Article GET IT
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma. JAMA oncology. 2020 Letter GET IT
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response. Blood advances. 2020 Academic Article GET IT
Times cited: 4
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Academic Article GET IT
Times cited: 8
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic. CA: a cancer journal for clinicians. 2020 Academic Article GET IT
Times cited: 12
Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant. Leukemia & lymphoma. 2020 Academic Article GET IT
Times cited: 6
Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 2020 Letter GET IT
Times cited: 2
Cord blood transplants supported by unrelated donor CD34⁺ progenitor cells. Bone marrow transplantation. 2020 Academic Article GET IT
Times cited: 3
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood advances. 2020 Academic Article GET IT
Times cited: 28
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 9
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. Blood advances. 2019 Academic Article GET IT
Times cited: 23
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 18
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma. Bone marrow transplantation. 2019 Academic Article GET IT
Times cited: 17
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leukemia & lymphoma. 2019 Academic Article GET IT
Times cited: 23
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018 Academic Article GET IT
Times cited: 38
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 3
Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients. Bone marrow transplantation. 2018 Academic Article GET IT
Times cited: 30
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 11
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 133
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34⁺ hematopoietic progenitor cells in patients with sickle cell disease: interim results. Haematologica. 2018 Academic Article GET IT
Times cited: 6
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. British journal of haematology. 2018 Academic Article GET IT
Times cited: 76
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34⁺ hematopoietic progenitor cells in patients with sickle cell disease: interim results. Haematologica. 2018 Academic Article GET IT
Times cited: 44
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 16
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience. Transfusion. 2017 Academic Article GET IT
Times cited: 2
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 23
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 12
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 8
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 37
Acute myeloid leukemia in a patient with thrombocytopenia with absent radii: A case report and review of the literature. Hematology/oncology and stem cell therapy. 2017 Review GET IT
Times cited: 9
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies. Transplantation. 2017 Academic Article GET IT
Times cited: 12
Haplo-cord transplant: HLA-matching determines graft dominance. Leukemia & lymphoma. 2016 Letter GET IT
Times cited: 7
Cord blood chimerism and relapse after haplo-cord transplantation. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 16
Prospective assessment of white matter integrity in adult stem cell transplant recipients. Brain imaging and behavior. 2016 Academic Article GET IT
Times cited: 17
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 67
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 15
Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 11
Bendamustine and stem-cell mobilization: not so bad!. Leukemia & lymphoma. 2016 Comment GET IT
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 47
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 16
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment. Clinical lymphoma, myeloma & leukemia. 2016 Academic Article GET IT
Times cited: 12
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. Haematologica. 2016 Academic Article GET IT
Times cited: 31
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 12
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2015 Academic Article GET IT
Times cited: 27
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 45
Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses. 2015 Academic Article GET IT
Times cited: 87
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration. Transfusion. 2015 Academic Article GET IT
Times cited: 12
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions. Transfusion. 2015 Academic Article GET IT
Times cited: 17
Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Clinical advances in hematology & oncology : H&O. 2014 Review GET IT
Times cited: 37
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 121
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis. Blood. 2014 Academic Article GET IT
Times cited: 112
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 27
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation. Bone marrow transplantation. 2014 Letter GET IT
Times cited: 17
A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain imaging and behavior. 2013 Academic Article GET IT
Times cited: 35
Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society. 2013 Academic Article GET IT
Times cited: 39
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 14
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 30
Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013 Academic Article GET IT
Times cited: 19
Peripheral-blood versus bone marrow stem cells. The New England journal of medicine. 2013 Letter GET IT
Times cited: 6
Avoiding pitfalls in bone marrow engraftment analysis: a case study highlighting the weakness of using buccal cells for determining a patient's constitutional genotype after hematopoietic stem cell transplantation. Cytotherapy. 2012 Academic Article GET IT
Times cited: 9
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 101
Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications. Leukemia & lymphoma. 2012 Letter GET IT
Times cited: 3
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma. Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 23
Addition of plerixafor to mobilization regimens in autologous peripheral blood stem cell transplants does not affect the correlation of preharvest hematopoietic precursor cell enumeration with first-harvest CD34+ stem cell yield. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Academic Article GET IT
Times cited: 12
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity. American journal of hematology. 2012 Letter GET IT
Times cited: 33
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone marrow transplantation. 2012 Academic Article GET IT
Times cited: 21
Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease. 2010 GET IT
Times cited: 38
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies. Clinical lymphoma, myeloma & leukemia. 2010 Academic Article GET IT
Times cited: 45
A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma. PloS one. 2010 Academic Article GET IT
Times cited: 11
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 18
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 100
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies. Annals of oncology : official journal of the European Society for Medical Oncology. 2008 Academic Article GET IT
Times cited: 66
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 46
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma. Blood. 2007 Academic Article GET IT
Times cited: 164
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2007 Academic Article GET IT
Times cited: 13
Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement. Leukemia & lymphoma. 2007 Academic Article GET IT
Times cited: 11
Stem cell transplantation for myelodysplastic syndromes: the lure of a cure. Current hematologic malignancy reports. 2007 Review GET IT
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2006 Academic Article GET IT
Times cited: 10
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma. Cancer. 2006 Academic Article GET IT
Times cited: 34
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 167
An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2004 Academic Article GET IT
Times cited: 54
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood. 2002 Academic Article GET IT
Times cited: 291
Gingival hyperplasia complicating acute myelomonocytic leukemia. Journal (Canadian Dental Association). 2000 Review GET IT
Times cited: 31
Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin. Cancer. 1998 Academic Article GET IT
Times cited: 8
Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 99
Pancreatitis post-bone marrow transplantation. 1996 GET IT
Times cited: 14
Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 39
Combination therapy with nucleoside analogs and alkylating agents. Leukemia. 1994 Academic Article GET IT
Times cited: 38
A phase II study of DuP 937 (Teloxantrone) in metastatic malignant melanoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCICCTG). Annals of oncology : official journal of the European Society for Medical Oncology. 1993 Academic Article GET IT
Times cited: 6
Pancytopenia due to hypersplenism after allogeneic bone marrow transplantation. 1992 GET IT
Times cited: 8
A meta-analysis of stages I and II Hodgkin's disease. Cancer. 1990 Review GET IT
Times cited: 40
Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease. Bone marrow transplantation. 1988 Academic Article GET IT
Times cited: 19
The predictive value of in-vitro techniques in acute non-lymphocytic leukemia. Leukemia research. 1987 Academic Article GET IT
Times cited: 1

more ...

less ...

Background

education and training

M.D., University of Manitoba Faculty of Medicine (Canada) 1979

Contact

full name

Tsiporah B Shore

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Tsiporah B Shore Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

webpage